Scienture Holdings - 16 Year Stock Price History | SCNX

Historical daily share price chart and data for Scienture Holdings since 2009 adjusted for splits and dividends. The latest closing stock price for Scienture Holdings as of May 23, 2025 is 0.88.
  • The all-time high Scienture Holdings stock closing price was 50460.60 on June 25, 2009.
  • The Scienture Holdings 52-week high stock price is 23.77, which is 2601.1% above the current share price.
  • The Scienture Holdings 52-week low stock price is 0.69, which is 21.6% below the current share price.
  • The average Scienture Holdings stock price for the last 52 weeks is 6.17.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
Scienture Holdings Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2025 2.2736 6.0034 6.0500 0.7818 0.8764 -85.51%
2024 7.6647 3.3329 21.1186 2.5604 6.0500 86.90%
2023 4.0829 2.7566 10.1918 2.4305 3.2371 -13.95%
2022 13.6847 24.5761 25.8843 2.7118 3.7621 -82.94%
2021 45.2874 50.5539 73.3545 22.0531 22.0531 -55.39%
2020 56.5213 70.0841 92.5109 38.3126 49.4325 -19.85%
2019 50.6651 22.3540 83.5403 20.2963 61.6740 266.67%
2018 25.9500 19.0629 56.0672 12.3348 16.8202 -33.33%
2017 29.3332 36.1522 47.6572 12.3348 25.2303 -2.17%
2016 45.9741 64.4773 70.0841 25.7910 25.7910 -58.18%
2015 64.7121 92.5109 98.1177 28.0336 61.6740 -35.29%
2014 111.3517 123.3480 448.5390 33.6404 95.3143 -19.05%
2013 51.7409 28.0337 151.3820 22.4269 117.7410 320.00%
2012 49.6012 61.6741 100.9210 16.8202 28.0337 -37.50%
2011 262.4072 465.3590 1009.2100 22.4269 44.8539 -90.36%
2010 2348.1910 7569.1000 8858.6400 465.3590 465.3590 -92.91%
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.012B $0.000B
Scienture Holdings Inc., through its wholly owned subsidiaries, Scienture and Integra Pharma Solutions, LLC, is a comprehensive pharmaceutical product company focused on providing enhanced value to patients, physicians and caregivers by offering novel specialty products to satisfy unmet market needs. Scienture Holdings Inc., formerly known as TRxADE Health Inc., is based in TAMPA, FL.
Stock Name Country Market Cap PE Ratio
Chugai Pharmaceutical (CHGCY) Japan $86.060B 32.28
Zoetis (ZTS) United States $72.110B 26.91
Daiichi Sankyo, - (DSNKY) Japan $50.342B 25.61
Takeda Pharmaceutical (TAK) Japan $45.851B 9.12
Sandoz Group AG (SDZNY) Switzerland $21.340B 0.00
Summit Therapeutics (SMMT) United States $19.139B 0.00
Merck (MKKGY) Germany $16.750B 12.27
United Therapeutics (UTHR) United States $13.925B 12.32
Shionogi (SGIOY) Japan $13.866B 13.89
Neurocrine Biosciences (NBIX) United States $11.789B 40.38
IPSEN (IPSEY) France $9.682B 0.00
Orion OYJ (ORINY) Finland $9.323B 25.21
Corcept Therapeutics (CORT) United States $8.069B 65.60
Stevanato Group S.p.A (STVN) Italy $6.847B 41.87
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $6.153B 0.00
Madrigal Pharmaceuticals (MDGL) United States $6.069B 0.00
Grifols, S.A (GRFS) Spain $5.586B 0.00
Ionis Pharmaceuticals (IONS) United States $5.294B 0.00
Ono Pharmaceutical (OPHLF) Japan $4.875B 14.83
Soleno Therapeutics (SLNO) United States $3.724B 0.00
Catalyst Pharmaceuticals (CPRX) United States $2.941B 10.30
Crinetics Pharmaceuticals (CRNX) United States $2.819B 0.00
Hypermarcas (HYPMY) Brazil $2.702B 17.77
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $2.253B 12.19
BioCryst Pharmaceuticals (BCRX) United States $2.174B 0.00
NewAmsterdam Pharma (NAMS) Netherlands $2.007B 0.00
Centessa Pharmaceuticals (CNTA) United Kingdom $1.686B 0.00
Recursion Pharmaceuticals (RXRX) United States $1.685B 0.00
Indivior (INDV) United States $1.546B 6.56
Evotec AG (EVO) Germany $1.431B 0.00
Guardian Pharmacy Services (GRDN) United States $1.429B 0.00
ARS Pharmaceuticals (SPRY) United States $1.426B 0.00
Dyne Therapeutics (DYN) United States $1.353B 0.00
Ocular Therapeutix (OCUL) United States $1.149B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.117B 22.35
Ardelyx (ARDX) United States $0.947B 0.00
Harrow (HROW) United States $0.944B 0.00
Collegium Pharmaceutical (COLL) United States $0.926B 4.99
Avadel Pharmaceuticals (AVDL) Ireland $0.859B 0.00
Enliven Therapeutics (ELVN) United States $0.823B 0.00
Cronos Group (CRON) Canada $0.790B 0.00
Xeris Biopharma Holdings (XERS) United States $0.763B 0.00
Akebia Therapeutics (AKBA) United States $0.743B 0.00
AleAnna (ANNA) United States $0.697B 0.00
KalVista Pharmaceuticals (KALV) United States $0.568B 0.00
USANA Health Sciences (USNA) United States $0.560B 12.17
Regulus Therapeutics (RGLS) United States $0.548B 0.00
Xencor (XNCR) United States $0.547B 0.00
Elite Pharmaceuticals (ELTP) United States $0.547B 0.00
Bioventus (BVS) United States $0.535B 13.56
Savara (SVRA) United States $0.506B 0.00
Relay Therapeutics (RLAY) United States $0.488B 0.00
Amylyx Pharmaceuticals (AMLX) United States $0.478B 0.00
Theravance Biopharma (TBPH) Cayman Islands $0.475B 0.00
Zevra Therapeutics (ZVRA) United States $0.469B 0.00
Altimmune (ALT) United States $0.468B 0.00
CytoDyn (CYDY) United States $0.424B 0.00
Oruka Therapeutics (ORKA) United States $0.419B 0.00
Siga Technologies (SIGA) United States $0.417B 8.72
Tourmaline Bio (TRML) United States $0.392B 0.00
Verve Therapeutics (VERV) United States $0.390B 0.00
Organogenesis (ORGO) United States $0.377B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.353B 9.53
Heron Therapeutics (HRTX) United States $0.285B 0.00
Nature's Sunshine Products (NATR) United States $0.265B 24.44
Aquestive Therapeutics (AQST) United States $0.227B 0.00
MediWound (MDWD) Israel $0.220B 0.00
ProKidney (PROK) United States $0.216B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.193B 0.00
Wellgistics Health (WGRX) United States $0.178B 0.00
Nanobiotix S.A (NBTX) France $0.172B 0.00
OmniAb (OABI) United States $0.172B 0.00
Avita Medical (RCEL) United States $0.169B 0.00
4D Molecular Therapeutics (FDMT) United States $0.167B 0.00
Esperion Therapeutics (ESPR) United States $0.159B 0.00
Journey Medical (DERM) United States $0.159B 0.00
Profound Medical (PROF) Canada $0.154B 0.00
Liminatus Pharma (LIMN) $0.143B 0.00
Korro Bio (KRRO) United States $0.139B 0.00
Inhibikase Therapeutics (IKT) United States $0.137B 0.00
Aclaris Therapeutics (ACRS) United States $0.136B 0.00
Aldeyra Therapeutics (ALDX) United States $0.135B 0.00
Lyell Immunopharma (LYEL) United States $0.125B 0.00
Larimar Therapeutics (LRMR) United States $0.124B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.123B 0.00
Nektar Therapeutics (NKTR) United States $0.123B 0.00
Protara Therapeutics (TARA) United States $0.122B 0.00
Innate Pharma SA (IPHYF) France $0.122B 0.00
VAXART, INC (VXRT) United States $0.107B 0.00
Achieve Life Sciences (ACHV) Canada $0.103B 0.00
Cassava Sciences (SAVA) United States $0.102B 0.00
Lexeo Therapeutics (LXEO) United States $0.102B 0.00
Ironwood Pharmaceuticals (IRWD) United States $0.100B 0.00
OptiNose (OPTN) United States $0.097B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.092B 0.00
Cardiol Therapeutics (CRDL) Canada $0.088B 0.00
Fractyl Health (GUTS) United States $0.086B 0.00
Arch Biopartners (ACHFF) Canada $0.082B 0.00
Galectin Therapeutics (GALT) United States $0.081B 0.00
Champions Oncology (CSBR) United States $0.080B 13.20
Cumberland Pharmaceuticals (CPIX) United States $0.076B 56.56
Pyxis Oncology (PYXS) United States $0.074B 0.00
ESSA Pharma (EPIX) Canada $0.074B 0.00
Inotiv (NOTV) United States $0.072B 0.00
Surrozen (SRZN) United States $0.070B 0.00
Dominari Holdings (DOMH) United States $0.069B 0.00
Assertio Holdings (ASRT) United States $0.068B 0.00
Vivani Medical (VANI) United States $0.068B 0.00
Unicycive Therapeutics (UNCY) United States $0.066B 0.00
Telomir Pharmaceuticals (TELO) United States $0.065B 0.00
Nutriband (NTRB) United States $0.064B 0.00
Context Therapeutics (CNTX) United States $0.063B 0.00
Metagenomi (MGX) United States $0.062B 0.00
Allergy Therapeutics (AGYTF) United Kingdom $0.059B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.057B 0.00
Gain Therapeutics (GANX) United States $0.053B 0.00
Prelude Therapeutics (PRLD) United States $0.051B 0.00
Century Therapeutics (IPSC) United States $0.049B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.049B 0.00
Mural Oncology (MURA) Ireland $0.047B 0.00
PMV Pharmaceuticals (PMVP) United States $0.047B 0.00
NRx Pharmaceuticals (NRXP) United States $0.047B 0.00
Avalo Therapeutics (AVTX) United States $0.042B 0.00
Karyopharm Therapeutics (KPTI) United States $0.040B 0.00
ElectroCore (ECOR) United States $0.037B 0.00
Iterum Therapeutics (ITRM) Ireland $0.037B 0.00
Acrivon Therapeutics (ACRV) United States $0.036B 0.00
Rafael Holdings (RFL) United States $0.034B 0.00
FibroGen (FGEN) United States $0.033B 0.00
SCYNEXIS (SCYX) United States $0.030B 0.00
PolyPid (PYPD) Israel $0.028B 0.00
China SXT Pharmaceuticals (SXTC) China $0.025B 0.00
CASI Pharmaceuticals (CASI) China $0.023B 0.00
Tempest Therapeutics (TPST) United States $0.023B 0.00
Enlivex Therapeutics (ENLV) Israel $0.023B 0.00
Natural Alternatives (NAII) United States $0.021B 0.00
Relmada Therapeutics (RLMD) United States $0.020B 0.00
Lipocine (LPCN) United States $0.020B 0.00
Mannatech (MTEX) United States $0.019B 0.00
BioVie (BIVI) United States $0.019B 0.00
Jupiter Neurosciences (JUNS) United States $0.019B 0.00
DURECT (DRRX) United States $0.017B 0.00
TherapeuticsMD (TXMD) United States $0.017B 0.00
GlycoMimetics (GLYC) United States $0.016B 0.00
VYNE Therapeutics (VYNE) United States $0.015B 0.00
MEI Pharma (MEIP) United States $0.015B 0.00
SHINECO (SISI) China $0.014B 0.00
Ernexa Therapeutics (ERNA) United States $0.014B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.013B 0.00
ProPhase Labs (PRPH) United States $0.013B 0.00
Cosmos Health (COSM) United States $0.013B 0.00
BioLineRx (BLRX) Israel $0.013B 0.00
Vivos Therapeutics (VVOS) United States $0.012B 0.00
Talphera (TLPH) United States $0.010B 0.00
Minerva Neurosciences (NERV) United States $0.010B 1.77
Ainos (AIMD) United States $0.010B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.009B 0.00
Phio Pharmaceuticals (PHIO) United States $0.009B 0.00
Addex Therapeutics (ADXN) Switzerland $0.009B 0.00
Biomerica (BMRA) United States $0.009B 0.00
Mangoceuticals (MGRX) United States $0.008B 0.00
Carisma Therapeutics (CARM) United States $0.008B 0.00
Citius Pharmaceuticals (CTXR) United States $0.007B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.007B 0.00
Traws Pharma (TRAW) United States $0.007B 0.00
Nuvilex (PMCB) United States $0.007B 0.00
TransCode Therapeutics (RNAZ) United States $0.006B 0.00
Klotho Neurosciences (KLTO) United States $0.006B 0.00
Lyra Therapeutics (LYRA) United States $0.006B 0.00
Indaptus Therapeutics (INDP) United States $0.006B 0.00
Incannex Healthcare (IXHL) Australia $0.006B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.006B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.005B 0.00
Plus Therapeutics (PSTV) United States $0.005B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.005B 0.00
Xenetic Biosciences (XBIO) United States $0.005B 0.00
Aptorum Group (APM) United Kingdom $0.005B 0.00
Alaunos Therapeutics (TCRT) United States $0.004B 0.00
Clearmind Medicine (CMND) Canada $0.004B 0.00
CERo Therapeutics Holdings (CERO) United States $0.004B 0.00
PainReform (PRFX) Israel $0.004B 0.00
Aditxt (ADTX) United States $0.004B 0.00
XORTX Therapeutics (XRTX) Canada $0.004B 0.00
SciSparc (SPRC) Israel $0.003B 0.00
InMed Pharmaceuticals (INM) Canada $0.003B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.003B 0.00
Conduit Pharmaceuticals (CDT) United States $0.003B 0.00
Redhill Biopharma (RDHL) Israel $0.003B 0.00
Jaguar Animal Health (JAGX) United States $0.003B 0.00
Heatwurx (PCSA) United States $0.003B 0.00
Qualigen Therapeutics (QLGN) United States $0.003B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.002B 0.00
TNF Pharmaceuticals (TNFA) United States $0.002B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.002B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.002B 0.00
Universe Pharmaceuticals INC (UPC) China $0.000B 0.00
4D Pharma (LBPS) United Kingdom $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00
Silence Therapeutics (SLN) United Kingdom $0.000B 0.00